Pharmaceuticals

Smoking Cessation Market Size, Share & Trends Analysis Report By Products (Smoking Cessation Therapy Products, Drug Therapy, Nicotine Sublingual Tablets, Nicotine Inhalers, E-cigarettes), By End-Users, Region And Segment Forecasts, 2023-2031

The Smoking Cessation Market Size is valued at 25380.0 Million in 2022 and is predicted to reach 53408.9 Million by the year 2031 at a 10.1 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: International frameworks and agreements like the WHO Framework Convention on Tobacco Control (FCTC) drive global efforts to reduce tobacco use as well as promote smoking cessation. Smoking is increasing...

Report ID: 1101  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Hyperpigmentation Disorder Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), By Region, Forecasts, 2024-2031

Hyperpigmentation Disorder Treatment Market Size was valued at USD 6.98 Bn in 2023 and is predicted to reach USD 12.54 Bn by 2031 at a 7.8% CAGR during the forecast period for 2024-2031. Hyperpigmentation disorder treatment issues can be treated with a combination of medical treatments and cosmetic operations that attempt to lessen the appearance and severity of hyperpigmented skin. The rising number of cases of hyperpigmentation disorder trea...

Report ID: 2504  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

rHu Albumin Market Size, Share & Trends Analysis Report By Source (Oryza Sativa, Pichia pastoris, Others), By Application, By End-User (Pharmaceutical and biotechnological industry, Research institutes), By Region, And Segment Forecasts, 2024-2031

The Global rHu Albumin Market Size is valued at 94.88 Million in 2023 and is predicted to reach 218.56 Million by the year 2031 at a 11.16 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The rise in health consciousness among people has increased the demand for albumin in the pharmaceutical production industry, which offers the market opportunities to grow and expand. The increasing awa...

Report ID: 1482  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 178

Polymer Drug Conjugates Market Size, Share & Trends Analysis Report By Product Type (Polymer-Dox Conjugates, Polymer-Paclitaxel Conjugates, Polymer-Camptothecin Conjugates, Polymer-Platinate Conjugates), By Application, By Region, And By Segment Forecasts, 2023-2031

The Polymer Drug Conjugates Market is expected to grow at a 32.0 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Growing demand for targeted drug delivery is driving the polymer-drug conjugates market. The increasing incidence of cancer, hepatitis, and other chronic conditions is fueling the need for more effective therapies, boosting the demand for polymer-drug conjugates. North Americ...

Report ID: 1316  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 185

Novel Spectrometry Platforms Market Size, Share & Trends Analysis Report By Type of Spectrometers (Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer, and X-Ray Fluorescence Spectrometer), By End-user, By Region, And By Segment Forecasts, 2023-2031

The Novel Spectrometry Platforms Market Size is valued at USD 13.47 Billion in 2023 and is predicted to reach USD 24.92 Billion by the year 2031 at an 8.4 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The increasing complex nature of drug molecules and the need for detailed analysis boost the demand for advanced spectrometry platforms. Rising environmental concerns and regulatory ...

Report ID: 1356  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Lab Workflow Optimization Market Size, Share & Trends Analysis Report, By Type of Solution (Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Laboratory Automation Systems, Scientific Data Management Systems (SDMS), Laboratory Execution Systems (LES), Inventory Management Systems, and Others), By End User (Pharmaceutical and Biotechnology Organizations, Academic and Research Institutes, Contract Research Organizations (CROs), Clinical Diagnostics Laboratories, Food and Beverage Laboratories, Environmental Testing Laboratories, and Others), By Region, Forecasts, 2024-2031

Lab Workflow Optimization Market Size is predicted to develop a 7.1% CAGR during the forecast period for 2024-2031. The primary drivers behind market expansion include the increasing prevalence of laboratory tests and the growing trend of outsourcing laboratory services. As the global population ages and expands, there's a heightened demand for healthcare services, particularly diagnostic testing. Consequently, there's a surge in laboratory te...

Report ID: 2496  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

3D Printing Photopolymer Market Size, Share & Trends Analysis Report, By Material (Polymers, Oligomers, Monomers, Additives, and Other), By Application (Surgical Models, Wearable Biosensors, Customized Prosthetics, Exoskeletons, and Hearing Aids), By Region, Forecasts, 2024-2031

3D Printing Photopolymer Market Size was valued at USD 929.5 Mn in 2023 and is predicted to reach USD 2,902.4 Mn by 2031 at a 15.5% CAGR during the forecast period for 2024-2031. The global 3D printing photopolymer market is expected to grow during the forecast period. The process of 3D printing material is also known as additive manufacturing, which is the production process of quick and easy 3D printed devices. The use of 3D printing allows ...

Report ID: 2486  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Erectile Dysfunction Drugs Market by Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel, Region And Segment Forecasts, 2024-2031

Erectile Dysfunction Drugs Market Size is valued at USD 2.58 billion in 2023 and is predicted to reach USD 4.60 billion by the year 2031 at a 7.7% CAGR during the forecast period for 2024-2031. Erectile dysfunction refers to the condition where an individual is unable to gain or maintain an erection for a sufficient duration to engage in sexual activity. Sedentary lifestyle-related chronic disorders, including obesity, heart disease, diabetes,...

Report ID: 2483  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Topical Drug Delivery Market Size, Share & Trends Analysis Report By Type (Semi-solids (Creams, Gels, Lotions), Solids (Suppositories), Liquids (Solutions), Transdermal Products), Route (Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres), Region And Segment Forecasts, 2023-2031

Topical Drug Delivery Market Size is valued at USD 208.25 billion in 2022 and is predicted to reach USD 418.70 billion by the year 2031 at a 8.1% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: The main reasons driving this market's growth are the rising rates of minor illnesses like acne and psoriasis as well as skin diseases like eczema. Transdermal delivery of biologics i...

Report ID: 2081  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180

Serotonin Supplement Market Size, Share & Trends Analysis Report, By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory), By Region, Forecasts, 2024-2031

Serotonin Supplement Market Size was valued at USD 939.6 Mn in 2023 and is predicted to reach USD 1,355.5 Mn by 2031 at a 4.8% CAGR during the forecast period for 2024-2031. Serotonin supplement is a neurotransmitter that helps control appetite, sleep, and mood; increasing blood levels of the neurotransmitter is the major objective of serotonin supplements. Mood, sleep, and mental health issues are common reasons people take these supplements....

Report ID: 2477  |  

Delivery: Immediate  |  

Published: May 2024   |  

No. of Pages: 180